Automating Delirium Severity in the ICU
Part of paid clinical trials in Rochester, Minnesota.
- Sponsor
- Mayo Clinic
- Study ID
- NCT06172491
- Status
- Recruiting
Conditions
- Delirium
- Encephalopathy
- Intensive Care Unit Delirium
Eligibility Criteria
- Sex
- ALL
- Age
- 50 Years - N/A
- Healthy Volunteers
- Not accepted
Study Details
The goal of this observational study is to develop a passive digital marker (PDM) for delirium severity and examine its performance in comparison to validated delirium severity tools in ICU patients \>50 years of age. The main questions it aims to answer are: * Is the trained convolutional neural network able to reliably measure delirium severity. * Is the Passive Digital Marker able to accurately measure delirium severity * Is the Passive Digital Marker acceptable and usable by frontline ICU nurse clinicians, patients, and their identified proxies (i.e., caregivers). Participants will: * Study participation involves a video camera recording you 24 hours per day while you are a patient in the Intensive Care Unit (ICU). * Study staff will visit you 4 times each day you are in the ICU. You will be asked questions each time they visit to train the digital marker and see differences between assessments and camera data.
Key Dates
- Start date
- Jan 15, 2023
- Status verified
- Apr 2026
- Primary completion
- May 31, 2027
- Completion
- May 31, 2028
Study Design
- Enrollment
- 400 participants (estimated)
Arms
- Arm: No Delirium SeverityPatients who did not experience a level of delirium severity (subsyndromal, mild, moderate, severe)
- Arm: Delirium SeverityPatients who did experience a level of delirium severity (subsyndromal, mild, moderate, severe)
Primary Outcome Measure
Delirium Severity [ Time Frame: 12-48 months ]
Central Contacts
- Heidi Lindroth, PH.D. R.N.507-284-3662
- Hannah Friesen1-507-284-2197
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Mayo Clinic | Rochester | Minnesota | 55905 | Heidi Lindroth, Ph.D., R.N. (PRINCIPAL_INVESTIGATOR) Anirban Bhattacharyya, M.D.,M.S (SUB_INVESTIGATOR) Arun Jayaraman, M.D,Ph.D (SUB_INVESTIGATOR) Linda Chlan, Ph.D (SUB_INVESTIGATOR) Vitaly Herasevich, M.D.,Ph.D (SUB_INVESTIGATOR) Alejandro Rabinstein, M.D. (SUB_INVESTIGATOR) Malaz Boustani, M.D. M.P.H. (SUB_INVESTIGATOR) |
Find similar trials in Rochester, MN
Related Studies
- CTSN Embolic Protection TrialRecruiting · Icahn School of Medicine at Mount Sinai · North Little Rock, Arkansas
- Interventions for Postoperative Delirium: Biomarker-3Recruiting · University of Wisconsin, Madison · Madison, Wisconsin
- Simultaneous Recumbent Cycling and Cognitive TrainingRecruiting · University of Missouri, Kansas City · Kansas City, Missouri
- Goal-Directed Sedation in Mechanically Ventilated Infants and ChildrenPHASE3 · Recruiting · Vanderbilt University Medical Center · Nashville, Tennessee